Results 1 to 10 of about 18,550 (219)

Energy metabolism in childhood neurodevelopmental disorders

open access: yesEBioMedicine, 2021
Whereas energy function in the aging brain and their related neurodegenerative diseases has been explored in some detail, there is limited knowledge about molecular mechanisms and brain networks of energy metabolism during infancy and childhood.
Oyarzábal A   +3 more
doaj   +1 more source

Hematopoietic Stem Cell Transplantation for Neurological Disorders: A Focus on Inborn Errors of Metabolism

open access: yesFrontiers in Cellular Neuroscience, 2022
Hematopoietic stem cells have been investigated and applied for the treatment of certain neurological disorders for a long time. Currently, their therapeutic potential is harnessed in autologous and allogeneic hematopoietic stem cell transplantation ...
Pedro de Vasconcelos   +2 more
doaj   +1 more source

Gene therapy for lysosomal storage diseases: Current clinical trial prospects

open access: yesFrontiers in Genetics, 2023
Lysosomal storage diseases (LSDs) are a group of metabolic inborn errors caused by defective enzymes in the lysosome, resulting in the accumulation of undegraded substrates.
Jun Kido   +4 more
doaj   +1 more source

Use of a neuron-glia genome-scale metabolic reconstruction to model the metabolic consequences of the Arylsulphatase a deficiency through a systems biology approach

open access: yesHeliyon, 2021
Metachromatic leukodystrophy (MLD) is a human neurodegenerative disorder characterized by progressive damage on the myelin band in the nervous system. MLD is caused by the impaired function of the lysosomal enzyme Arylsulphatase A (ARSA).
Olga Y. Echeverri-Peña   +6 more
doaj   +1 more source

Metabolic evaluation of children with global developmental delay [PDF]

open access: yesKorean Journal of Pediatrics, 2015
Global developmental delay (GDD) is a relatively common early-onset chronic neurological condition, which may have prenatal, perinatal, postnatal, or undetermined causes.
So-Hee Eun, Si Houn Hahn
doaj   +1 more source

Cystathionine beta synthase deficiency and brain edema associated with methionine excess under betaine supplementation: Four new cases and a review of the evidence. [PDF]

open access: yes, 2020
CBS deficient individuals undergoing betaine supplementation without sufficient dietary methionine restriction can develop severe hypermethioninemia and brain edema. Brain edema has also been observed in individuals with severe hypermethioninemia without
Barea, Jaime J   +10 more
core   +1 more source

Neuroimaging of Basal Ganglia in Neurometabolic Diseases in Children

open access: yesBrain Sciences, 2020
Diseases primarily affecting the basal ganglia in children result in characteristic disturbances of movement and muscle tone. Both experimental and clinical evidence indicates that the basal ganglia also play a role in higher mental states.
Justyna Paprocka   +3 more
doaj   +1 more source

Neurodegeneration with Brain Iron Accumulation: Diagnosis and Management [PDF]

open access: yesJournal of Movement Disorders, 2015
Neurodegeneration with brain iron accumulation (NBIA) encompasses a group of inherited disorders that share the clinical features of an extrapyramidal movement disorder accompanied by varying degrees of intellectual disability and abnormal iron ...
Penelope Hogarth
doaj   +1 more source

Tetrahydrocannabinol in Pediatrics: Room for Improvement?

open access: yesMedical Cannabis and Cannabinoids, 2023
Introduction: The use of medical cannabis in pediatrics is not common in clinical practice, and there is a lack of prospective studies, especially in pediatric subpopulations.
Charlotte De Gier   +4 more
doaj   +1 more source

The International Working Group on Neurotransmitter related Disorders (iNTD): A worldwide research project focused on primary and secondary neurotransmitter disorders [PDF]

open access: yes, 2016
INTRODUCTION: Neurotransmitters are chemical messengers that enable communication between the neurons in the synaptic cleft. Inborn errors of neurotransmitter biosynthesis, breakdown and transport are a group of very rare neurometabolic diseases ...
Cortès-Saladelafont, Elisenda   +17 more
core   +4 more sources

Home - About - Disclaimer - Privacy